Endocrine Abstracts

The predominant treatment modality for patients with bronchial neuro-endocrine tumours (excluding small cell lung cancer) is surgical. Despite this, disease can recur, in both local and metastatic form, even many years after treatment. The follow-up of patients after surgery should aim to improve clinical outcomes and avoid harm. Follow-up can be in the form of clinical review, biochemical tests and radiological imaging. The evidence base for the optimal form of follow up for ...